Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stryckmans

Showing results (71-80 of 131) with videos related to

Pageof 14
Sort By:
Stem Cells (Dayton, Ohio)|November 1, 1994
Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free mediumC De Bruyn, A Delforge, D Bron, et al.
Bone Marrow Transplantation|February 2, 1997
Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantationR Trenschel, M Bernier, P Stryckmans, et al.
Revue Medicale De Bruxelles|December 1, 1988
[The contribution of monoclonal antibodies to the diagnosis and prognosis of acute leukemias (apropos of 100 cases)]M Bernier, M Massy, A Delforge, et al.
Bruxelles Medical|March 1, 1970
[Treatment of acute leukemia: current perspectives and relative curability]C Cauchie, Y Kenis, R Maurus, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitroP Dodion, C Sanders, W Rombaut, et al.
Blood Cells|January 1, 1982
Scientific basis and criticism of current therapy of acute leukemiaP Stryckmans, A Delforge, D Bron, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1983
Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemiaC Laduron, A Coune, G Atassi, et al.
Experimental Hematology|August 1, 1989
Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cellsL Lagneaux, J P Marie, A Delforge, et al.
Investigational New Drugs|January 1, 1986
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivativesD Bron, P Dodion, M Rozencweig, et al.
Journal of Hematotherapy|April 1, 1997
Ex vivo expansion of CD34 + CD38- cord blood cellsC De Bruyn, A Delforge, D Bron, et al.
Pageof 14

Showing results (71-80 of 131) with videos related to

Sort By:
Pageof 14
Stem Cells (Dayton, Ohio)|November 1, 1994
Modulation of human cord blood progenitor cell growth by recombinant human interleukin 3 (IL-3), IL-6, granulocyte-macrophage colony stimulating factor (GM-CSF) and stem cell factor (SCF) in serum-supplemented and serum-free mediumC De Bruyn, A Delforge, D Bron, et al.
Bone Marrow Transplantation|February 2, 1997
Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantationR Trenschel, M Bernier, P Stryckmans, et al.
Revue Medicale De Bruxelles|December 1, 1988
[The contribution of monoclonal antibodies to the diagnosis and prognosis of acute leukemias (apropos of 100 cases)]M Bernier, M Massy, A Delforge, et al.
Bruxelles Medical|March 1, 1970
[Treatment of acute leukemia: current perspectives and relative curability]C Cauchie, Y Kenis, R Maurus, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitroP Dodion, C Sanders, W Rombaut, et al.
Blood Cells|January 1, 1982
Scientific basis and criticism of current therapy of acute leukemiaP Stryckmans, A Delforge, D Bron, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1983
Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemiaC Laduron, A Coune, G Atassi, et al.
Experimental Hematology|August 1, 1989
Comparison of in vitro inhibition of etoposide (VP16) on leukemic and normal myeloid, erythroid clonogenic cellsL Lagneaux, J P Marie, A Delforge, et al.
Investigational New Drugs|January 1, 1986
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivativesD Bron, P Dodion, M Rozencweig, et al.
Journal of Hematotherapy|April 1, 1997
Ex vivo expansion of CD34 + CD38- cord blood cellsC De Bruyn, A Delforge, D Bron, et al.
Pageof 14